Full Text View
Tabular View
No Study Results Posted
Related Studies
A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Cambridge Health Alliance.
Recruitment status was  Active, not recruiting
Study NCT00195845   Information provided by Cambridge Health Alliance

First Received on September 12, 2005.   Last Updated on March 28, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Disorder
Additional conditions recognized in this trial
Cognition Disorders
More general conditions related to this trial
Affective Disorders, Psychotic
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Mood Disorders
Interventions listed in this trial
Galantamine
More general drug interventions related to this trial
Autonomic Agents
Central Nervous System Agents
Cholinergic Agents
Cholinesterase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nootropic Agents
Parasympathomimetics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Cambridge Health Alliance
Northwestern University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services